Market Snapshot: Softmax /Jp Holds Firm Amid Quiet Volatility
Softmax /Jp (3671.T) finished the trading day unchanged, trading flat at 0 % during a 24‑hour period that closed at 09:09 AM Central Europe on Wednesday, 21 st. The single share of Softmax /Jp can currently be acquired for roughly JPY 300 on major exchanges, a price that sits well below its 200‑day simple moving average of JPY 322.22.
With a supply of 24 million shares, the company’s market capitalization stands at JPY 7.5 billion. Over the last 24 hours, roughly JPY 5 million worth of Softmax /Jp shares changed hands—an amount that is modest in the context of a firm whose shares have risen by 1.3 % since the end of the previous month. The highest price the stock has ever reached in the past 52 weeks was JPY 416 on 30 Oct 2025, while the 52‑week low was JPY 270 on 29 Jun 2026.
Comparative Performance
| Stock | 24‑hour change | Current price (JPY) | Market cap (JPY bn) | P/E ratio |
|---|---|---|---|---|
| Solekia (9867.T) | 0 % | 10 360 | 8.9 | 5.22 |
| Fuji United (416A.T) | +1.49 % | 1 370 | 8.9 | 7.1 |
| Kuze (2708.T) | +0.26 % | 1 901 | 8.8 | 5.44 |
| Wintest (6721.T) | +33.11 % | 242 | 8.9 | — |
| Create Medic (5187.T) | +0.54 % | 1 115 | 8.9 | 18.2 |
While Softmax /Jp’s performance has been essentially static, other peers have exhibited a range of movements—from modest gains at Fuji United and Kuze to a dramatic 33 % surge at Wintest. The disparity underscores the volatility inherent in Japan’s health‑care technology sector and highlights the challenges companies face in maintaining investor confidence.
Company Profile
SoftMax Co., Ltd—formerly Victor Keisanki Kyushu Hanbai Co., Ltd until its rebranding in 2001—has been a fixture in Japan’s medical‑information landscape since its founding in 1974. Headquartered in Tokyo, the company delivers a suite of web‑based electronic medical charting and accounting solutions. Its product portfolio spans electronic medical records, ordering systems, health‑checkup platforms, radiology and rehabilitation department systems, surgical solutions, and integrated health‑care information ecosystems.
SoftMax went public on 12 March 2013 and is listed on the Tokyo Stock Exchange under the ticker 3671.T. Its website, accessible at www.s‑max.co.jp, provides comprehensive details on its technology stack, client base, and corporate governance.
Investor Takeaway
Softmax /Jp’s flat trading day may appear unremarkable at first glance, but the underlying figures paint a more nuanced picture. A share price that sits below its 200‑day average and a market cap that lags behind its peers suggest that the market is still evaluating the company’s long‑term growth prospects. With a modest trading volume of only JPY 5 million in the last day, liquidity remains limited, potentially amplifying price swings in the event of significant news.
In an environment where competitors like Fuji United and Wintest are generating noticeable price movements, Softmax /Jp must deliver compelling operational and financial results to shift investor sentiment from neutrality to optimism. Stakeholders should monitor upcoming earnings releases, product launches, and regulatory developments closely, as these factors will be decisive in determining whether Softmax /Jp can break out of its current plateau and return to a trajectory of sustained growth.
